Cas 327038-37-9,1'-(4-Trifluoromethoxybenzyl)-3, 4-dihydrospiro[5H-1-benzazepine-2(1H), 4'-piperidin]-5-one

327038-37-9

Post Buying Request

Basic information

Product Name: 1'-(4-Trifluoromethoxybenzyl)-3, 4-dihydrospiro[5H-1-benzazepine-2(1H), 4'-piperidin]-5-one
Synonyms:
CAS NO:327038-37-9
Molecular Formula:
Molecular Weight: 404.432
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1'-(4-Trifluoromethoxybenzyl)-3, 4-dihydrospiro[5H-1-benzazepine-2(1H), 4'-piperidin]-5-one(CAS DataBase Reference)
NIST Chemistry Reference: 1'-(4-Trifluoromethoxybenzyl)-3, 4-dihydrospiro[5H-1-benzazepine-2(1H), 4'-piperidin]-5-one(327038-37-9)
EPA Substance Registry System: 1'-(4-Trifluoromethoxybenzyl)-3, 4-dihydrospiro[5H-1-benzazepine-2(1H), 4'-piperidin]-5-one(327038-37-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 327038-37-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

327038-37-9 Suppliers

Recommended suppliers

327038-37-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 327038-37-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,7,0,3 and 8 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 327038-37:
(8*3)+(7*2)+(6*7)+(5*0)+(4*3)+(3*8)+(2*3)+(1*7)=129
129 % 10 = 9
So 327038-37-9 is a valid CAS Registry Number.

327038-37-9Upstream product

327038-37-9Downstream Products

327038-37-9Relevant academic research and scientific papers

Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof

-

, (2008/06/13)

One aspect of the present invention relates to spirocyclic compounds. Another aspect of the present invention relates to the use of the spirocyclic compounds as ligands for mammalian G-protein-coupled receptors or sigma receptors. The present invention al

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 327038-37-9